Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Sees Significant Growth in Short Interest

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 2,800 shares, an increase of 300.0% from the October 31st total of 700 shares. Based on an average trading volume of 3,500 shares, the days-to-cover ratio is currently 0.8 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Down 0.2 %

Shares of NASDAQ HROWL traded down $0.05 during midday trading on Wednesday, reaching $25.35. 2,385 shares of the stock traded hands, compared to its average volume of 5,479. The company’s 50 day moving average is $25.41 and its 200 day moving average is $25.28. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a one year low of $23.65 and a one year high of $25.73.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Tuesday, October 15th were given a $0.5391 dividend. The ex-dividend date was Tuesday, October 15th. This represents a $2.16 annualized dividend and a yield of 8.51%.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.